| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Emerging roles of Wnts in the adult nervous system.
|
Nat Rev Neurosci
|
2009
|
2.69
|
|
2
|
Histone H2AX-dependent GABA(A) receptor regulation of stem cell proliferation.
|
Nature
|
2008
|
2.24
|
|
3
|
Differential regulation of midbrain dopaminergic neuron development by Wnt-1, Wnt-3a, and Wnt-5a.
|
Proc Natl Acad Sci U S A
|
2003
|
2.14
|
|
4
|
Liver X receptors and oxysterols promote ventral midbrain neurogenesis in vivo and in human embryonic stem cells.
|
Cell Stem Cell
|
2009
|
1.84
|
|
5
|
A Wnt1-regulated genetic network controls the identity and fate of midbrain-dopaminergic progenitors in vivo.
|
Development
|
2006
|
1.79
|
|
6
|
Derivation of mouse embryonic stem cells.
|
Nat Protoc
|
2006
|
1.76
|
|
7
|
Wnt-5a induces Dishevelled phosphorylation and dopaminergic differentiation via a CK1-dependent mechanism.
|
J Cell Sci
|
2007
|
1.65
|
|
8
|
Neurogenin 2 is required for the development of ventral midbrain dopaminergic neurons.
|
Development
|
2006
|
1.58
|
|
9
|
Cholestenoic acids regulate motor neuron survival via liver X receptors.
|
J Clin Invest
|
2014
|
1.55
|
|
10
|
Beta-arrestin is a necessary component of Wnt/beta-catenin signaling in vitro and in vivo.
|
Proc Natl Acad Sci U S A
|
2007
|
1.46
|
|
11
|
Communication via gap junctions underlies early functional and beneficial interactions between grafted neural stem cells and the host.
|
Proc Natl Acad Sci U S A
|
2010
|
1.31
|
|
12
|
Wnt5a-treated midbrain neural stem cells improve dopamine cell replacement therapy in parkinsonian mice.
|
J Clin Invest
|
2008
|
1.29
|
|
13
|
Wnt-3a utilizes a novel low dose and rapid pathway that does not require casein kinase 1-mediated phosphorylation of Dvl to activate beta-catenin.
|
Cell Signal
|
2006
|
1.26
|
|
14
|
Interactions of Wnt/beta-catenin signaling and sonic hedgehog regulate the neurogenesis of ventral midbrain dopamine neurons.
|
J Neurosci
|
2010
|
1.26
|
|
15
|
Purified Wnt-5a increases differentiation of midbrain dopaminergic cells and dishevelled phosphorylation.
|
J Neurochem
|
2005
|
1.24
|
|
16
|
GSK-3beta inhibition/beta-catenin stabilization in ventral midbrain precursors increases differentiation into dopamine neurons.
|
J Cell Sci
|
2004
|
1.24
|
|
17
|
Cerebrospinal fluid steroidomics: are bioactive bile acids present in brain?
|
J Biol Chem
|
2009
|
1.23
|
|
18
|
The extracellular domain of Lrp5/6 inhibits noncanonical Wnt signaling in vivo.
|
Mol Biol Cell
|
2008
|
1.23
|
|
19
|
An efficient method for the derivation of mouse embryonic stem cells.
|
Stem Cells
|
2005
|
1.20
|
|
20
|
Wnt5a regulates midbrain dopaminergic axon growth and guidance.
|
PLoS One
|
2011
|
1.18
|
|
21
|
Neural progenitor cells engineered to secrete GDNF show enhanced survival, neuronal differentiation and improve cognitive function following traumatic brain injury.
|
Eur J Neurosci
|
2006
|
1.14
|
|
22
|
Wnt5a regulates ventral midbrain morphogenesis and the development of A9-A10 dopaminergic cells in vivo.
|
PLoS One
|
2008
|
1.14
|
|
23
|
Nurr1-RXR heterodimers mediate RXR ligand-induced signaling in neuronal cells.
|
Genes Dev
|
2003
|
1.13
|
|
24
|
The p75 neurotrophin receptor interacts with multiple MAGE proteins.
|
J Biol Chem
|
2002
|
1.13
|
|
25
|
Wnt5a cooperates with canonical Wnts to generate midbrain dopaminergic neurons in vivo and in stem cells.
|
Proc Natl Acad Sci U S A
|
2013
|
1.12
|
|
26
|
Beta-arrestin and casein kinase 1/2 define distinct branches of non-canonical WNT signalling pathways.
|
EMBO Rep
|
2008
|
1.12
|
|
27
|
Ventral midbrain glia express region-specific transcription factors and regulate dopaminergic neurogenesis through Wnt-5a secretion.
|
Mol Cell Neurosci
|
2005
|
1.09
|
|
28
|
Brain endogenous liver X receptor ligands selectively promote midbrain neurogenesis.
|
Nat Chem Biol
|
2012
|
1.09
|
|
29
|
Midbrain dopaminergic neurogenesis and behavioural recovery in a salamander lesion-induced regeneration model.
|
Development
|
2007
|
1.09
|
|
30
|
Wnt/beta-catenin signaling blockade promotes neuronal induction and dopaminergic differentiation in embryonic stem cells.
|
Stem Cells
|
2009
|
1.08
|
|
31
|
NTera2: a model system to study dopaminergic differentiation of human embryonic stem cells.
|
Stem Cells Dev
|
2005
|
1.08
|
|
32
|
Identification of midbrain floor plate radial glia-like cells as dopaminergic progenitors.
|
Glia
|
2008
|
1.06
|
|
33
|
Functional integration of grafted neural stem cell-derived dopaminergic neurons monitored by optogenetics in an in vitro Parkinson model.
|
PLoS One
|
2011
|
1.06
|
|
34
|
Differential expression of Wnts after spinal cord contusion injury in adult rats.
|
PLoS One
|
2011
|
1.03
|
|
35
|
Vang-like protein 2 and Rac1 interact to regulate adherens junctions.
|
J Cell Sci
|
2010
|
1.02
|
|
36
|
Parkin protects dopaminergic neurons from excessive Wnt/beta-catenin signaling.
|
Biochem Biophys Res Commun
|
2009
|
1.02
|
|
37
|
Neural progenitors organize in small-world networks to promote cell proliferation.
|
Proc Natl Acad Sci U S A
|
2013
|
1.01
|
|
38
|
Inhibition of mitochondrial complex III blocks neuronal differentiation and maintains embryonic stem cell pluripotency.
|
PLoS One
|
2013
|
1.00
|
|
39
|
Disruption of EphA/ephrin-a signaling in the nigrostriatal system reduces dopaminergic innervation and dissociates behavioral responses to amphetamine and cocaine.
|
Mol Cell Neurosci
|
2004
|
0.99
|
|
40
|
Valproic acid induces differentiation and inhibition of proliferation in neural progenitor cells via the beta-catenin-Ras-ERK-p21Cip/WAF1 pathway.
|
BMC Cell Biol
|
2008
|
0.98
|
|
41
|
Function of Wnts in dopaminergic neuron development.
|
Neurodegener Dis
|
2006
|
0.97
|
|
42
|
Wnt5a is required for endothelial differentiation of embryonic stem cells and vascularization via pathways involving both Wnt/beta-catenin and protein kinase Calpha.
|
Circ Res
|
2008
|
0.97
|
|
43
|
Analysis of bioactive oxysterols in newborn mouse brain by LC/MS.
|
J Lipid Res
|
2012
|
0.97
|
|
44
|
Dynamic temporal and cell type-specific expression of Wnt signaling components in the developing midbrain.
|
Exp Cell Res
|
2006
|
0.96
|
|
45
|
Targeted lipidomic analysis of oxysterols in the embryonic central nervous system.
|
Mol Biosyst
|
2009
|
0.96
|
|
46
|
Control of neural stem cell adhesion and density by an electronic polymer surface switch.
|
Langmuir
|
2008
|
0.94
|
|
47
|
Ca2+ and cAMP signaling in human embryonic stem cell-derived dopamine neurons.
|
Stem Cells Dev
|
2010
|
0.94
|
|
48
|
The beta-chemokines CCL2 and CCL7 are two novel differentiation factors for midbrain dopaminergic precursors and neurons.
|
Exp Cell Res
|
2008
|
0.93
|
|
49
|
Wnts are expressed in the spinal cord of adult mice and are differentially induced after injury.
|
J Neurotrauma
|
2014
|
0.92
|
|
50
|
Delayed dopaminergic neuron differentiation in Lrp6 mutant mice.
|
Dev Dyn
|
2010
|
0.90
|
|
51
|
Cripto as a target for improving embryonic stem cell-based therapy in Parkinson's disease.
|
Stem Cells
|
2005
|
0.90
|
|
52
|
SFRP1 and SFRP2 dose-dependently regulate midbrain dopamine neuron development in vivo and in embryonic stem cells.
|
Stem Cells
|
2012
|
0.90
|
|
53
|
The antimicrobial peptide rCRAMP is present in the central nervous system of the rat.
|
J Neurochem
|
2005
|
0.89
|
|
54
|
Wnt2 regulates progenitor proliferation in the developing ventral midbrain.
|
J Biol Chem
|
2009
|
0.87
|
|
55
|
Heterotrimeric G protein-dependent WNT-5A signaling to ERK1/2 mediates distinct aspects of microglia proinflammatory transformation.
|
J Neuroinflammation
|
2012
|
0.86
|
|
56
|
Alpha-chemokines regulate proliferation, neurogenesis, and dopaminergic differentiation of ventral midbrain precursors and neurospheres.
|
Stem Cells
|
2008
|
0.86
|
|
57
|
Crucial role of TrkB ligands in the survival and phenotypic differentiation of developing locus coeruleus noradrenergic neurons.
|
Development
|
2003
|
0.86
|
|
58
|
Inhibition of canonical Wnt signaling promotes gliogenesis in P0-NSCs.
|
Biochem Biophys Res Commun
|
2009
|
0.86
|
|
59
|
A small synthetic cripto blocking Peptide improves neural induction, dopaminergic differentiation, and functional integration of mouse embryonic stem cells in a rat model of Parkinson's disease.
|
Stem Cells
|
2010
|
0.85
|
|
60
|
Tiam1 regulates the Wnt/Dvl/Rac1 signaling pathway and the differentiation of midbrain dopaminergic neurons.
|
Mol Cell Biol
|
2012
|
0.85
|
|
61
|
Genetic interaction between Lrp6 and Wnt5a during mouse development.
|
Dev Dyn
|
2010
|
0.85
|
|
62
|
Region-specific effects of glia on neuronal induction and differentiation with a focus on dopaminergic neurons.
|
Glia
|
2003
|
0.83
|
|
63
|
Increased Wnt levels in the neural tube impair the function of adherens junctions during neurulation.
|
Mol Cell Neurosci
|
2005
|
0.82
|
|
64
|
Microarray analyses support a role for Nurr1 in resistance to oxidative stress and neuronal differentiation in neural stem cells.
|
Stem Cells
|
2006
|
0.82
|
|
65
|
WNT unrelated activities in commercially available preparations of recombinant WNT3a.
|
J Cell Biochem
|
2010
|
0.82
|
|
66
|
Stromal factors SDF1α, sFRP1, and VEGFD induce dopaminergic neuron differentiation of human pluripotent stem cells.
|
J Neurosci Res
|
2012
|
0.81
|
|
67
|
Novel isoforms of the TFIID subunit TAF4 modulate nuclear receptor-mediated transcriptional activity.
|
Biochem Biophys Res Commun
|
2004
|
0.81
|
|
68
|
Cxcl12/Cxcr4 signaling controls the migration and process orientation of A9-A10 dopaminergic neurons.
|
Development
|
2013
|
0.81
|
|
69
|
Spatio-temporal expression pattern of frizzled receptors after contusive spinal cord injury in adult rats.
|
PLoS One
|
2012
|
0.81
|
|
70
|
BMPs, FGF8 and Wnts regulate the differentiation of locus coeruleus noradrenergic neuronal precursors.
|
J Neurochem
|
2006
|
0.80
|
|
71
|
Dkk1 regulates ventral midbrain dopaminergic differentiation and morphogenesis.
|
PLoS One
|
2011
|
0.80
|
|
72
|
Transplantable midbrain dopamine neurons: a moving target.
|
Exp Neurol
|
2010
|
0.79
|
|
73
|
The Ryk receptor is expressed in glial and fibronectin-expressing cells after spinal cord injury.
|
J Neurotrauma
|
2013
|
0.78
|
|
74
|
Stem-cell-based strategies for the treatment of Parkinson's disease.
|
Neurodegener Dis
|
2007
|
0.77
|
|
75
|
Peptide-presenting two-dimensional protein matrix on supported lipid bilayers: an efficient platform for cell adhesion.
|
Biointerphases
|
2007
|
0.77
|
|
76
|
BMP-2 and cAMP elevation confer locus coeruleus neurons responsiveness to multiple neurotrophic factors.
|
J Neurobiol
|
2002
|
0.77
|
|
77
|
Neurturin is a neuritogenic but not a survival factor for developing and adult central noradrenergic neurons.
|
J Neurochem
|
2002
|
0.76
|
|
78
|
Striatopallidal neurons are selectively protected by neurturin in an excitotoxic model of Huntington's disease.
|
J Neurobiol
|
2002
|
0.75
|
|
79
|
Retraction Notice to: Vulnerability of Glioblastoma Cells to Catastrophic Vacuolization and Death Induced by a Small Molecule.
|
Cell
|
2017
|
0.75
|